Concentration (U/ml) | Fold increases | Flow cytometry | ||
---|---|---|---|---|
7 days | 14 days | CD33, 34, 45, 14, 16, 133 | ||
After isolation | N/A | N/A |
| |
Control | Non-stimulated | 1.2 ± 0.13 | 6.4 ± 1.2 |
|
0.1% BSA | 1.3 ± 0.17 | 6.8 ± 1.6 |
| |
IL-1β | 1 | 5 ± 1a | 6.3 ± 0.12 | N/A |
10 | 13 ± 2.2a,b | 59.1 ± 13.3a,b |
| |
100 | 15.8 ± 2.5a,b | 136.8 ± 23.3a,b |
| |
1,000 | 19.4 ± 8.6a,b | 142.7 ± 23.5a,b |
| |
10,000 | 10.5 ± 2.8a,b | 97 ± 22.4a,b |
| |
IL-3 | 10 | 11.8 ± 1.6a,b | 71.2 ± 10.5a,b |
|
100 | 15.5 ± 1.6a,b | 82.9 ± 14.5a,b |
| |
1,000 | 15.2 ± 1.4a,b | 79.6 ± 9.9a,b |
| |
IL-6 | 10 | 1.5 ± 0.51 | 2.8 ± 0.58 |
|
100 | 1.2 ± 0.22 | 5.2 ± 1.2 |
| |
1,000 | 1.3 ± 0.21 | 4.6 ± 0.77 |
|